Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07576595 · ClinicalTrials.gov registry record · NA

Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans

A NA study, sponsored by Louisiana State University Health Sciences Center in New Orleans.

Recruiting
Registry status
NA
Development phase
250
Enrollment target

NCT07576595: Recruiting NA study, sponsored by Louisiana State University Health Sciences Center in New Orleans.

NCT07576595 is a NA study that is actively recruiting participants, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07576595, a NA study, is actively recruiting participants, sponsored by Louisiana State University Health Sciences Center in New Orleans.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target

Study Summary

This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.

Primary Outcome

Stage of change in smoking cessation behavior

Interventions

  • BEHAVIORAL Smoking cessation multilevel Intervention

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-04-17
Est. Completion 2030-06
Phase NA

What NCT07576595 shows while recruiting

NCT07576595 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which Smoking cessation multilevel Intervention is the first listed.

NCT07576595 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07576595 about?

NCT07576595 is a clinical study titled "Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans". This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of h...

What is the current status of trial NCT07576595?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-04-17. Estimated completion is 2030-06.

What interventions are being tested in trial NCT07576595?

The interventions under investigation include: Smoking cessation multilevel Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07576595?

This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07576595's enrollment target sits among peer trials

250 410th of 2000 higher than 1,567 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07576595, the US trial registry maintained by the National Library of Medicine. NCT07576595 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.